<code id='1DB2853A74'></code><style id='1DB2853A74'></style>
    • <acronym id='1DB2853A74'></acronym>
      <center id='1DB2853A74'><center id='1DB2853A74'><tfoot id='1DB2853A74'></tfoot></center><abbr id='1DB2853A74'><dir id='1DB2853A74'><tfoot id='1DB2853A74'></tfoot><noframes id='1DB2853A74'>

    • <optgroup id='1DB2853A74'><strike id='1DB2853A74'><sup id='1DB2853A74'></sup></strike><code id='1DB2853A74'></code></optgroup>
        1. <b id='1DB2853A74'><label id='1DB2853A74'><select id='1DB2853A74'><dt id='1DB2853A74'><span id='1DB2853A74'></span></dt></select></label></b><u id='1DB2853A74'></u>
          <i id='1DB2853A74'><strike id='1DB2853A74'><tt id='1DB2853A74'><pre id='1DB2853A74'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:35778
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Biden administration plans revamp of organ transplant system
          Biden administration plans revamp of organ transplant system

          SurgicalinstrumentsandsupplieslayonatableduringakidneytransplantsurgeryatMedStarGeorgetownUniversity

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Emergency workers more likely to restrain Black patients: study

          MishaFriedman/GettyImagesInthechaoticenvironmentofanemergencyroom,hospitalstafferssometimesfacethequ